ISSN 2149-2263 | E-ISSN 2149-2271 Home      
 
Volume : 22 Issue : 3
Current Issue Archive Popular Article Ahead of Print

   
Quick Search





 
Use of aspirin in diabetic patients [Anatol J Cardiol]
Anatol J Cardiol. 2007; 7(Suppl 2): 5-8

Use of aspirin in diabetic patients

Sedat Türkoğlu1, Adnan Abacı2
1Department of Cardiology, Faculty of Medicine, Gazi University, Ankara, Turkey
2Department of Cardiology, Faculty of Medicine, Gazi University, Ankara

Major cardiovascular events cause about 80% of the total mortality in diabetic patients. It has been shown that diabetic patients have hyperactive platelets. It may be expected that aspirin, through its antiplatelet action, could change the risk for vascular events in people with diabetes. However, some data suggest that aspirin may be less effective than expected in preventing cardiovascular events in patients with diabetes. In this paper, we review the aspirin use in diabetics with respect to cardiovascular endpoints.

Keywords: Aspirin, diabetes mellitus, coronary artery disease


Diyabetik hastalarda aspirin

Sedat Türkoğlu1, Adnan Abacı2
1Department of Cardiology, Faculty of Medicine, Gazi University, Ankara, Turkey
2Department of Cardiology, Faculty of Medicine, Gazi University, Ankara

Anahtar Kelimeler: Aspirin, diyabet, koroner arter hastalığı


Sedat Türkoğlu, Adnan Abacı. Use of aspirin in diabetic patients. Anatol J Cardiol. 2007; 7(Suppl 2): 5-8


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share


Similar articles
PubMed
Google Scholar




 
 
KARE Publishing | Copyright © 2018 Turkish Society of Cardiology